Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

19. Dezember 2017 08:30 ET | Quelle: Hemispherx Biopharma, Inc.

Hemispherx Highlights Year-To-Date Progress, Outlines Key Objectives

Letter to Shareholders Posted on Website Revenue Up, Burn Rate Down Dramatically; Progress Cited with FDA Discussions on Ampligen; Manufacturing Facility for FDA-Approved Alferon N Fully Repaired;...
10. November 2016 08:30 ET | Quelle: Hemispherx Biopharma, Inc.

Hemispherx Biopharma Announces Conference Call to Provide Quarterly Business Update on November 15, 2016

PHILADELPHIA, Nov. 10, 2016 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE MKT:HEB) (the “Company” or “Hemispherx”) announced today that it anticipates filing its 2016 third quarter financial...
26. August 2015 10:00 ET | Quelle: AIM ImmunoTech Inc.

Hemispherx Biopharma's Judgment Unanimously Affirmed Against Cato Capital

WILMINGTON, Del., Aug. 26, 2015 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE Amex:HEB) (the "Company" or "Hemispherx") announced that on Friday the Third Circuit Court of Appeals upheld the...